The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Genetically Engineered Animals

Biotech Trends of 2009: Three Biggest Losers

When we started the blog almost a year ago, we identified what we thought would be key trends for biotech investors and companies to watch.  Most panned out, but a few turned out to be… not so trendy.  You can call them premature (if you’re feeling generous) or call them dumb (if you’re feeling mean); [...]

Allocating Spending to Support R&D: UK, U.S. and Canadian Approaches

The U.S., Canada and the UK have all acknowledged the central importance of R&D even in these recessionary times.  However, the three national governments have decided to focus their spending on different steps of the R&D equation: Education: UK Takes the Long View British PM Gordon Brown, in a speech this week, identified three priorities: research, education and training, [...]

GTC Biotherapeutics goes for a Regulatory Double Combo Shot

GTC Biotherapeutics, which recently saw ATryn approved, announced a collaboration agreement with AgResearch Limited, a New Zealand Crown Research Institute.  AgResearch will develop genetically modified animals capable of producing the building blocks for “biosimilar” versions of existing products that will begin coming off U.S. patent in 2014. The double combo shot:  the success of the collaboration depends on [...]

Trends in 2009: Genetically Engineered Animal Approvals

The past few weeks have seen at least three conspicuous developments towards a functional regulatory regime that will lead to increasing numbers of FDA approvals for Genetically Engineered (GE) animals: The FDA released their final Guidance on Regulation of Genetically Engineered Animals Containing Heritable Recombinant DNA Constructs (pdf), as well as a FAQ and comment responses. The FDA approved ATryn, a [...]

Follow

Get every new post delivered to your Inbox.

Join 84 other followers